# Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis

> **NCT00546663** · NA · COMPLETED · sponsor: **CF Therapeutics Development Network Coordinating Center** · enrollment: 19 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** inhaled 7% hypertonic saline (HS)

## Key facts

- **NCT ID:** NCT00546663
- **Lead sponsor:** CF Therapeutics Development Network Coordinating Center
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-05
- **Final completion:** 2008-07
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2011-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00546663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00546663, "Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00546663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*